Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp (ADPT), sold 12,991 shares at $3.44 ($45K) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Open-market sale of $45k ADPT by Chief Commercial Officer, MRD. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.43 | 6,016 | $21K | 46.2% |
| 2 | $3.44 | 6,975 | $24K | 53.8% |
| Total | $3.44 avg | 12,991 | $45K | 100% |
| Filing → |
| ADPT | SELL | 2026-08-03 | $31K | — | Filing → |
| ADPT | SELL | 2026-07-20 | $115K | — | Filing → |
| ADPT | SELL | 2026-07-06 | $11K | — | Filing → |